Prescription and use of ward‐delivered nasal high‐flow oxygen and non‐invasive ventilation for people with acute respiratory failure

Internal Medicine Journal 2026 Open access

Read full text
Authors: Aiden Cushnahan, Amelia Harrison, Catherine Buchan, Matthew T. Naughton, Eli J. Dabscheck, Natasha Smallwood
DOI: 10.1111/imj.70418
Cited by: 1
References: 19

Abstract

Nasal high-flow therapy with oxygen entrained (HFNO) and non-invasive ventilation (NIV) are important therapies for managing acute respiratory failure (ARF) in the ward-based setting. The European Respiratory Society released guidelines in 2022 recommending the use of HFNO over conventional oxygen therapy and NIV in patients with hypoxic ARF. We conducted a 12-month retrospective audit of ward-based HFNO and NIV use at our hospital to determine prescribing practices for these therapies and to assist with the safe implementation of the recent European Respiratory Society guidelines. We found significant variation in prescribing practices for both HFNO and NIV.

Fields of Study & Subjects

Respiratory Support and Mechanisms Nosocomial Infections in ICU Airway Management and Intubation Techniques

Publication details

Journal / source
Internal Medicine Journal
Publisher
Wiley
Volume
56
Issue
5
Pages
908–913
Publication date
5 April 2026
Language
EN